Aptamer Group (LSE:APTA) Net Margin % : -606.38% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Aptamer Group Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Aptamer Group's Net Income for the six months ended in Dec. 2023 was £-1.81 Mil. Aptamer Group's Revenue for the six months ended in Dec. 2023 was £0.30 Mil. Therefore, Aptamer Group's net margin for the quarter that ended in Dec. 2023 was -606.38%.

The historical rank and industry rank for Aptamer Group's Net Margin % or its related term are showing as below:

LSE:APTA' s Net Margin % Range Over the Past 10 Years
Min: -677.39 Med: -65.41 Max: -46.1
Current: -677.39

LSE:APTA's Net Margin % is ranked worse than
68.68% of 1028 companies
in the Biotechnology industry
Industry Median: -154.37 vs LSE:APTA: -677.39

Aptamer Group Net Margin % Historical Data

The historical data trend for Aptamer Group's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptamer Group Net Margin % Chart

Aptamer Group Annual Data

Trend

Mar19

Mar20

Jun22

Jun23

Net Margin %

-46.10

-78.95

-51.86

-447.26

Aptamer Group Semi-Annual Data
	Mar19	Mar20	Dec21	Jun22	Dec22	Jun23	Dec23
Net Margin %	Get a 7-Day Free Trial			-80.12	-37.29	-259.31	-706.11	-606.38

Competitive Comparison of Aptamer Group's Net Margin %

For the Biotechnology subindustry, Aptamer Group's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aptamer Group's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aptamer Group's Net Margin % distribution charts can be found below:

* The bar in red indicates where Aptamer Group's Net Margin % falls into.

Aptamer Group Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Aptamer Group's Net Margin for the fiscal year that ended in Jun. 2023 is calculated as

Net Margin	=	Net Income (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	-7.836	/	1.752
	=	-447.26 %

Aptamer Group's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-1.807	/	0.298
	=	-606.38 %

Aptamer Group (LSE:APTA) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Aptamer Group Net Margin % Related Terms

Thank you for viewing the detailed overview of Aptamer Group's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Aptamer Group (LSE:APTA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptamer Group PLC (LSE:APTA) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

P0J:Germany

Address

Innovation Way, Windmill House, York, GBR, YO10 5BR

Website

https://www.aptamergroup.com

Aptamer Group PLC provides Optimer binders for use in research, diagnostics and therapeutics. It strives to deliver transformational solutions that meet the needs of researchers and developers across the life sciences through the use of its proprietary Optimer technology. Its businesses: Aptamer Solutions for custom Optimer development, Aptamer Diagnostics for in-house and collaborative Optimer-based diagnostic development and Aptamer Therapeutics for the development of Optimer-based therapeutics.

Aptamer Group (LSE:APTA) Headlines

No Headlines